Low-Dose Systemic Phosphodiesterase III Inhibitor Pimobendan Combined with Prostacyclin Therapy in a Patient with Severe Primary Pulmonary Hypertension

Author： Watanabe Eri   Shiga Tsuyoshi   Matsuda Naoki   Kajimoto Katsuya   Naganuma Miyoko   Kawai Akihiko   Kasanuki Hiroshi  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.17, Iss.4, 2003-07, pp. : 375-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Therapy of Primary Pulmonary Hypertension

By Nagaya Noritoshi  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 75-85

Adis International

Access to resources Recommend Favorite

Dexfenfluramine: Pulmonary hypertension in a patient with systemic lupus erythematosus: case report

By  

Reactions Weekly, Vol. 1, Iss. 1280, 2009-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Efficacy, Safety and Tolerability of Combined Low-Dose Simvastatin-Fenofibrate Treatment in Primary Mixed Hyperlipidaemia

By C. Stefanutti  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 465-477

Adis International

Access to resources Recommend Favorite

Methotrexate with low-dose prednisone shows potential as a therapy for severe refractory alopecia areata

By  

Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Low-dose testosterone therapy improves body composition and sexual function in men with chronic obstructive pulmonary disease

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite